Tolerability of carboplatin, paclitaxel and erlotinib as first-line treatment of ovarian cancer. Conference

Blank, SV, Curtin, JP, Goldman, NA et al. (2005). Tolerability of carboplatin, paclitaxel and erlotinib as first-line treatment of ovarian cancer. . JOURNAL OF CLINICAL ONCOLOGY, 23(16), 467S-467S.

cited authors

  • Blank, SV; Curtin, JP; Goldman, NA; Fusco, E; Lesko, Z; Hochster, H; Runowicz, CD; Wadler, S; Muggia, FM

sustainable development goals

authors

date/time interval

  • May 13, 2005 -

publication date

  • June 1, 2005

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • FL, Orlando

Conference

  • 41st Annual Meeting of the American-Society-of-Clinical-Oncology

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 467S

end page

  • 467S

volume

  • 23

issue

  • 16